Rosewell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-12-2024
- Paid Up Capital ₹ 1.50 M
as on 07-12-2024
- Company Age 37 Year, 19 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 9.07%
(FY 2023)
- Profit 152.91%
(FY 2023)
- Ebitda 100.17%
(FY 2023)
- Net Worth 2.62%
(FY 2023)
- Total Assets 2.31%
(FY 2023)
About Rosewell Pharmaceuticals
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Umesh Sharma and Mukesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24200MH1987PTC045603
- Company No.
045603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 1987
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbi-400013, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rosewell Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Sharma  | Director | 16-Dec-1987 | Current |
| Mukesh Kumar | Director | 20-Aug-2018 | Current |
Financial Performance of Rosewell Pharmaceuticals.
Rosewell Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.07% increase. The company also saw a substantial improvement in profitability, with a 152.91% increase in profit. The company's net worth moved up by a moderate rise of 2.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rosewell Pharmaceuticals?
In 2023, Rosewell Pharmaceuticals had a public holding of 99.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rosewell Pharmaceuticals?
Unlock and access historical data on people associated with Rosewell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rosewell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rosewell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
